Japan’s economic outlook for 2025 projects a modest GDP growth of 1.0%, driven by recovering domestic demand, supported by wage growth and fiscal measures. Inflation is expected to rise to 2.5%, influenced by wage increases and yen depreciation.
The Bank of Japan faces challenges in normalizing monetary policy while managing its large JGB holdings. Geopolitical risks, particularly related to U.S. defense talks and regional tensions, add uncertainty. Trade risks, including potential U.S. tariffs on key sectors like automotive and technology, could hinder exports, while nearshoring may help boost the tech sector’s resilience.
Corporate capital expenditure is forecast to grow by 1.5%, driven by investments in green technologies, automation, and public infrastructure. Despite these positive factors, risks remain from trade policy shifts and external demand, making domestic consumption crucial for economic stability. – IIF
Japan’s economic outlook for 2025 projects cautious optimism, with GDP growth expected at 1.0%, driven by domestic demand and wage-supported consumption. Private consumption is forecast to rise 1.4%, bolstered by wage growth and tax cuts, while services consumption, particularly in tourism, will outpace goods. Corporate capital expenditure is set to grow 1.5%, fueled by digital transformation and green investments.
The Bank of Japan faces challenges in normalizing monetary policy amid a large bond portfolio and a weak yen, which could impact fiscal stability. Exports are expected to grow 2.6%, but trade risks, especially from U.S. tariffs, remain. Inflation is projected at 2.5%, with wage-driven and import-related price pressures.
Fiscal policy will remain expansionary, with significant infrastructure and defense spending, though debt sustainability remains a concern. Overall, Japan’s resilience depends on managing domestic strengths while navigating external uncertainties, particularly from trade and geopolitical risks.
More Malaysian women in finance are pursuing entrepreneurship, strengthening SME growth, innovation, leadership diversity, and…
Partnership integrates Sandoz biosimilars into Alpro Pharmacy’s OncoHelp programme to support patients from government hospitals…
Dayang Enterprise's 1QFY26 net profit soared 140.8% year-on-year to RM22.2 million, driven by improved margins…
Telekom Malaysia's 1QFY26 net profit fell short of expectations, impacted by a 5G-related write-down and…
MM Computer Systems Bhd offers customized IT solutions and outsourcing services, serving diverse clients including…
Malaysian organizations are struggling with AI-driven cyber threats, fragmented systems and alert overload, accelerating demand…
This website uses cookies.